Adebrelimab Combined With Chemoradiotherapy for Locally Advanced Unresectable Esophageal Squamous Cell Carcinoma (ESCC)
Clinical trial NCT06420908 · WITHDRAWN
Trial details
- NCT number
- NCT06420908
- Sponsor
- Hebei Medical University Fourth Hospital
- Status
- WITHDRAWN
- Phase
- Not Applicable
- Study type
- INTERVENTIONAL
- Start date
- 2024-05-30
- Primary completion
- 2026-05-30
- Enrollment
- 0
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.